Please login to the form below

Not currently logged in
Email:
Password:

trial failure

This page shows the latest trial failure news and features for those working in and with pharma, biotech and healthcare.

Trial failure for bintrafusp alfa casts doubt on GSK/Merck KGaA’s cancer alliance

Trial failure for bintrafusp alfa casts doubt on GSK/Merck KGaA’s cancer alliance

Bispecific antibody fails in non-small cell lung cancer trial. Bintrafusp alfa – the novel immunotherapy at the centre of a major alliance between GlaxoSmithKline (GSK) and Merck KGaA – has failed in ... Although GSK has not issued a press release

Latest news

More from news
Approximately 26 fully matching, plus 76 partially matching documents found.

Latest Intelligence

  • Transforming clinical trial data into a long-term asset Transforming clinical trial data into a long-term asset

    Moreover, published literature tends to catalogue successful clinical trials, but data from an unsuccessful trial – provided its failure did not result from safety issues – can still help make the case for ... Yet it seems that numerous archives of

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    A subsequent leak about the apparent failure of remdesivir in a Chinese trial then dampened expectations again. ... A clinical trial of Regeneron’s drug is scheduled to start in June.

  • For trials without tribulations, we must improve patient experience For trials without tribulations, we must improve patient experience

    The result of this consultation is Havas Lynx Group’s latest white paper‘Patient Centricity on Trial’. ... This kind of simple, practical question can be the difference between success and failure of a clinical trial, and is usually only raised by

  • VIDEO interview: Neil Weir, UCB VIDEO interview: Neil Weir, UCB

    Avoiding failure. By taking this approach to research, it's possible to avoid one of the major pitfalls facing pharma today – the high cost of late-stage trial failure. ... Particularly when we have high failure rates in late stages in clinical studies,

  • Customer valuation in pharma Customer valuation in pharma

    Multiple studies have pegged the probability of clinical trial success at between 13-20 per cent. ... This estimate has remained constant over decades. Among the major reasons for clinical trial failure are problems that rest squarely in the domain of

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Alzheimer's: the numbers we cannot forget

    This is one of the highest clinical trial failure rates in healthcare. ... Failures in these trials have been associated with lack of efficacy, excessive side effects, or challenges in trial execution; leaving patients and HCPs with 5 therapies to choose

  • A forward march for adaptive designs

    For example, poor dose selection in phase II is frequently cited as one of the top causes of late-stage clinical trial failure. ... As such, it has prioritised phase II/III adaptive trial designs as well as other types of study.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
integrated medhealth communication

imc group is a leading, independent global healthcare communication group that enables client’s brands to connect with healthcare professionals, payers...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....